4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001179110-21-006778
EVP, Chief Scientific Officer acquired 32,701 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Shearman Mark S · EVP, Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-06-14 | Grant or award : show line 1 in the form | +32,701 | 32,701 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-06-14 | Grant or award : show line 2 in the form Stock Option (right to buy) | +52,718 | 52,718 | D |
Loading xslF345X03/edgar.xml…